Click Therapeutics

We combine neuroscience with the power of software to create patient-centric digital treatments.

Latest funding

$50M Series B+ · April 13, 2026

Website: clicktherapeutics.com.

X: @Click_Tx · 767 followers.

LinkedIn: click-therapeutics-inc-.

Category: Health and bio.

Sectors: Biotechnology, Health Care, Medical Device, Pharmaceutical, Therapeutics.

Stage: Series B+.

Based in: New York, United States.

Founded: 2012.

Last round: Apr 13, 2026 · 216 days ago.

Headcount: 101–250 employees.

On Recent Funding since: Sep 29, 2026.

Signals

X account@Click_Tx · created Jul 18, 2012 (14 years old) · 767 followers

Website registeredApr 7, 2012 (14 years old)

About Click Therapeutics

Discover our prescription digital therapeutics and software-enhanced drug therapies.

TIMELINE · MONEY RAISED

@Click_Tx·Raised $50M in 1 sourced round·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Date	Round	Amount	Lead	Source
Apr 13, 2026	Series B+	$50M	BBoehringer Ingelheim	fundraisingfox.com
Oct 22, 2021	Series B+	undisclosed	AAccelmed	clicktherapeutics.com

DB
David Benshoof Klein Founder & CEO

LinkedIn · source: clicktherapeutics.com
BL
Bruce Leuchter Founder

@bruceleuchtermd · LinkedIn
MM
Michael McAllister Founder

LinkedIn
VG
Victor Gao Founder

LinkedIn
AS
Austin Speier Chief Strategy Officer
DJ
Demetrius Johnson Principle Tech Lead of Mobile Development

Acquired company	Price	Announced
PProGevity Neuroscience	Not disclosed publicly	Date not given
BBetter Therapeutics	Not disclosed publicly	Date not given

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/click-therapeutics (get a free API key).